PFAS, Endocrine Disruption, and Shale Gas Development

The Environmental Health Project (EHP) and Halt the Harm Network (HHN) hosted a webinar on PFAS, Endocrine Disruption, and Shale Gas Development on Tuesday, September 21, 2021, at 7 p.m. View the recording of the webinar here.

Per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals,” are widely used in many consumer products and industrial applications. Because of their chemical structure, these substances do not break down, which results in their accumulation in the environment and in the body. Health impacts associated with exposure to PFAS are many and varied.

Dusty Horwitt, J.D., author of PSR's recently released report Fracking with “Forever Chemicals," discussed the evidence of PFAS within oil and gas operations, the problems with the lack of transparency, and the regulations needed to better protect public health. In addition, Katherine Pelch, Ph.D., environmental health science and policy analyst and assistant professor at the University of North Texas Health Science Center, discussed the health impacts of PFAS, focusing specifically on endocrine disruption. Dr. Pelch will also discuss the PFAS-TOX Database and regulation and exposure mitigation.

The webinar was moderated by Makenzie White, MPH, LSW, Public Health Manager at EHP.